the world's headlines, one feed
LifeMine Therapeutics has hauled in $263 million across two venture rounds as it seeks to test a potentially safer, more convenient immunosuppressant in transplant patients. The infusion includes a previously unannounced $75 million Series D ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A CDC director officially confirmed, Moderna's mRNA flu shot approved, and other health news from Morning Rounds
The device could provide additional records concerning the federal response to the COVID-19 pandemic as a Senate committee considers holding Fauci in contempt of Congress.
Dr. Stacy Norton was only 7 years old when her mother died of colon cancer, one of several family members struck by aggressive tumors at unusually young ages. Decades…
Chemotherapy remains a cornerstone of treatment for head and neck cancers, the seventh-most-common type of cancer worldwide.